Celltech and Biogen Idec Form Autoimmune Disease Collaboration
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 45 (Table of Contents)
Published: 4 Mar-2004
DOI: 10.3833/pdr.v2004.i45.821 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Celltech, Britain’s largest biotechnology company and Biogen Idec agreed to collaborate in the research, development and commercialization of antibodies against CD40 ligand (CD40L) for the treatment of autoimmune disease...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS